Annual SG&A:
$48.79M+$7.47M(+18.08%)Summary
- As of today, STOK annual SG&A is $48.79 million, with the most recent change of +$7.47 million (+18.08%) on December 31, 2024.
- During the last 3 years, STOK annual SG&A has risen by +$16.90 million (+52.97%).
- STOK annual SG&A is now at all-time high.
Performance
STOK SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$16.03M+$765.00K(+5.01%)Summary
- As of today, STOK quarterly SG&A is $16.03 million, with the most recent change of +$765.00 thousand (+5.01%) on September 30, 2025.
- Over the past year, STOK quarterly SG&A has increased by +$3.33 million (+26.28%).
- STOK quarterly SG&A is now at all-time high.
Performance
STOK Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$1.71B+$40.57M(+2.32%)Summary
- As of today, STOK TTM SG&A is -$1.71 billion, with the most recent change of +$40.57 million (+2.32%) on September 30, 2025.
- Over the past year, STOK TTM SG&A has dropped by -$1.76 billion (-3772.75%).
- STOK TTM SG&A is now -6551.09% below its all-time high of -$25.71 million.
Performance
STOK TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
STOK Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +18.1% | +26.3% | -3772.8% |
| 3Y3 Years | +53.0% | +61.2% | -4568.8% |
| 5Y5 Years | +309.6% | +186.1% | -9031.8% |
STOK Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +53.0% | at high | +70.8% | -83.1% | +7.7% |
| 5Y | 5-Year | at high | +309.6% | at high | +186.1% | -460.9% | +7.7% |
| All-Time | All-Time | at high | +2394.6% | at high | +2328.3% | -6551.1% | +7.7% |
STOK Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $16.03M(+5.0%) | $58.79M(+6.0%) |
| Jun 2025 | - | $15.26M(+4.2%) | $55.45M(+4.2%) |
| Mar 2025 | - | $14.65M(+14.1%) | $53.23M(+9.1%) |
| Dec 2024 | $48.79M(+18.1%) | $12.84M(+1.2%) | $48.79M(+4.8%) |
| Sep 2024 | - | $12.69M(-2.6%) | $46.56M(+5.5%) |
| Jun 2024 | - | $13.04M(+27.6%) | $44.14M(+6.8%) |
| Mar 2024 | - | $10.22M(-3.7%) | $41.33M(+0.0%) |
| Dec 2023 | $41.32M(+6.2%) | $10.61M(+3.3%) | $41.32M(+3.1%) |
| Sep 2023 | - | $10.27M(+0.4%) | $40.09M(+0.8%) |
| Jun 2023 | - | $10.23M(+0.2%) | $39.77M(+0.3%) |
| Mar 2023 | - | $10.21M(+8.8%) | $39.65M(+1.9%) |
| Dec 2022 | $38.92M(+22.0%) | $9.38M(-5.6%) | $38.92M(+1.7%) |
| Sep 2022 | - | $9.94M(-1.7%) | $38.27M(+4.4%) |
| Jun 2022 | - | $10.11M(+6.6%) | $36.65M(+6.3%) |
| Mar 2022 | - | $9.49M(+8.7%) | $34.47M(+8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $31.90M(+53.0%) | $8.72M(+4.8%) | $31.90M(+10.5%) |
| Sep 2021 | - | $8.32M(+4.9%) | $28.86M(+10.4%) |
| Jun 2021 | - | $7.93M(+14.8%) | $26.13M(+12.4%) |
| Mar 2021 | - | $6.91M(+21.7%) | $23.24M(+11.5%) |
| Dec 2020 | $20.85M(+75.0%) | $5.68M(+1.4%) | $20.85M(+8.9%) |
| Sep 2020 | - | $5.60M(+11.1%) | $19.14M(+13.5%) |
| Jun 2020 | - | $5.04M(+11.6%) | $16.87M(+18.4%) |
| Mar 2020 | - | $4.52M(+13.6%) | $14.24M(+19.6%) |
| Dec 2019 | $11.91M(+170.2%) | $3.98M(+19.7%) | $11.91M(+50.1%) |
| Sep 2019 | - | $3.32M(+37.2%) | $7.93M(+72.1%) |
| Jun 2019 | - | $2.42M(+10.6%) | $4.61M(+110.6%) |
| Mar 2019 | - | $2.19M(+231.7%) | $2.19M(+231.7%) |
| Dec 2018 | $4.41M(+125.5%) | - | - |
| Mar 2018 | - | $660.00K | $660.00K |
| Dec 2017 | $1.96M | - | - |
FAQ
- What is Stoke Therapeutics, Inc. annual SG&A?
- What is the all-time high annual SG&A for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. annual SG&A year-on-year change?
- What is Stoke Therapeutics, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. quarterly SG&A year-on-year change?
- What is Stoke Therapeutics, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. TTM SG&A year-on-year change?
What is Stoke Therapeutics, Inc. annual SG&A?
The current annual SG&A of STOK is $48.79M
What is the all-time high annual SG&A for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high annual SG&A is $48.79M
What is Stoke Therapeutics, Inc. annual SG&A year-on-year change?
Over the past year, STOK annual SG&A has changed by +$7.47M (+18.08%)
What is Stoke Therapeutics, Inc. quarterly SG&A?
The current quarterly SG&A of STOK is $16.03M
What is the all-time high quarterly SG&A for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high quarterly SG&A is $16.03M
What is Stoke Therapeutics, Inc. quarterly SG&A year-on-year change?
Over the past year, STOK quarterly SG&A has changed by +$3.33M (+26.28%)
What is Stoke Therapeutics, Inc. TTM SG&A?
The current TTM SG&A of STOK is -$1.71B
What is the all-time high TTM SG&A for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high TTM SG&A is -$25.71M
What is Stoke Therapeutics, Inc. TTM SG&A year-on-year change?
Over the past year, STOK TTM SG&A has changed by -$1.76B (-3772.75%)